4-Bromo-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one, 95+%, 25g

Dimethyl 3,5-Pyridinedicarboxylate>98.0%(GC)(T)25g

2-((3-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propyl)thio)benzoic acid, 5mg

tert-Butyl 5-bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-1-carboxylate, 97%, 250mg

h-d-glu(otbu)-oh, 95.0%, 10g

1,5-dimethyl-1H-indazole-3-carbonitrile, 95.0%, 1g

4-(5-Methyl-1,3,4-oxadiazol-2-yl)phenol, 95.0%, 5g

BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]-, 98%, 25mg

5-Bromo-6-chloronicotinamide, 98%, 5g

(4-Chloro-3-(diethylcarbamoyl)phenyl)boronic acid, 98%, 1g

Pellicola adesiva con 2 tacche per vetrini, 0,50 mm 25 pz

tert-Butyl (1-amino-1-oxopropan-2-yl)carbamate, 97%, 5g

(R)-ethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 1g